EXAGEN INC.
corporate_fare Company Profile
EXAGEN INC. (NASDAQ:XGN) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 11 items for XGN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-04, rated 7/10. Across its 11 most recent items scored 7 or higher, the top rating is 8/10, with 3 rated 8 or above. Recent SEC coverage for XGN spans 10-Q, 8-K, 10-K.
Recent high-impact activity:
- Exagen Q2 Revenue Jumps 16% on 11% Test Volume Growth, Loss Narrows Sharply
- Exagen Beats Q2 Revenue by 12%, Raises 2026 Outlook on Test Volume Surge
- Exagen Reports Strong Q2 Results: Revenue Up 16%, Net Loss Reduced, Guidance Raised
- Systematic Review Confirms AVISE Lupus Superiority, Bolstering Exagen's Market Position
- Exagen Reports Q1 Revenue Growth, Maintains 12-Month Liquidity, Amends Debt Facility
Financial Snapshot
Short Interest & Short Volume
3.59 days to coverFINRA reported short interest of 800,344 shares in XGN as of the September 15, 2026 settlement, a 7.4% decrease from the prior period — about 3.6 days to cover at its recent average daily volume. On October 2, 2026, 8.3% of XGN volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.